patrick.net

We have previously reported that chronic wounds to the legs and feet of diabetic patients constitute the biggest market for placenta products, and the need for wound dressings has been outstripping the supply of donated placentas2. From a business perspective, this unmet medical need has created a bit of a gold rush. Many hospitals have recently launched placenta procurement programs, either by partnering with third party companies or by developing in-house programs. In some cases, hospitals have ended long-term relationships collecting donations for public cord blood banks, to instead collect donations for placenta procurement companies, which allegedly offer the hospitals more financially lucrative relationships.

The global placenta market size is projected to witness a significant surge from its 2023 valuation of approximately USD 1.2 billion to an anticipated USD 2.4 billion by 2032, growing at a CAGR of 8% over the forecast period. This remarkable growth is primarily driven by the increasing demand for placenta-based products across diverse industries, such as cosmetics, pharmaceuticals, and nutraceuticals. As consumers become more aware of the potential health and beauty benefits associated with placenta, there is a corresponding rise in product innovation and development aimed at harnessing these advantages. The market's expansion is further supported by ongoing research and technological advancements, which continue to unveil new applications and benefits of the placenta.